International Journal of Stroke

International Journal of Stroke is the official journal of the World Stroke Organization, published ten times a year by SAGE, founded in 2006 and edited by Hugh S. Markus, with a 2025 Journal Impact Factor of 6.9《国际卒中杂志》（International Journal of Stroke）是世界卒中组织的官方期刊，由（SAGE）每年出版 10 期，2006 年创刊，主编为（Hugh S. Markus），2025 年影响因子为 6.9。

Scope

• The journal concentrates on the clinical aspects of stroke from around the world该刊聚焦全球范围内的卒中的临床问题。
• Basic science contributions in areas of clinical interest are also published期刊也发表具临床意义的基础科学成果。
• Reviews of current topics encompass both recent advances of global interest and those more important in specific regions主题综述既涵盖具全球意义的最新进展，也涵盖对特定地区更重要的进展。
• Items of news interest from all parts of the world are regularly featured来自世界各地的新闻类内容为常规栏目。
• Consensus statements, guidelines and study protocols are among the published article types已发表的文章类型包括共识声明、指南与研究方案。
• Associate editors from Europe, Asia, South America and North America coordinate segments such as reviews, leading opinions and research来自欧洲、亚洲、南美与北美的副主编分别负责综述、领衔观点与研究等板块。

History

• The journal was created by the World Stroke Organization, which itself was formed in 2006 from the merger of the International Stroke Society and the World Stroke Federation该刊由世界卒中组织创办，该组织本身于 2006 年由国际卒中学会与世界卒中联盟合并而成。
• It has been published by SAGE from the outset as the flagship journal of the organisation期刊自创办起即由（SAGE）出版，是该组织的旗舰期刊。
• It offers free access as a major benefit to members of the World Stroke Organization, who also receive a monthly link to the full issue as a PDF期刊为世界卒中组织会员提供免费阅读权益，会员每月还可收到整期 PDF 链接。
• It appears under print ISSN 1747-4930 and electronic ISSN 1747-4949, with ten issues a year期刊印刷 ISSN 为 1747-4930，电子 ISSN 为 1747-4949，每年 10 期。
• It is a hybrid open access journal and a member of the Committee on Publication Ethics该刊为混合开放获取期刊，也是出版伦理委员会的成员。
• Its Journal Impact Factor moved from 5.266 in 2021 through 6.948 in 2022 and 8.7 in 2024 to 6.9 in 2025, ranking 26th among 296 clinical neurology journals其影响因子由 2021 年的 5.266 经 2022 年的 6.948 与 2024 年的 8.7 变为 2025 年的 6.9，在 296 种临床神经病学期刊中列第 26 位。

Editors

• The Editor-in-Chief is Hugh S. Markus of the University of Cambridge主编为剑桥大学的（Hugh S. Markus）。
• The editor makes final decisions on publication based on reviewer comments and recommendations from a team of associate editors who manage peer review within their disciplines主编依据审稿意见与各学科副主编的推荐，对是否发表作最终决定，副主编在各自学科内组织同行评审。
• An editorial office recruitment notice in 2019 set out the responsibilities of the post, including final decisions on all submitted articles2019 年的主编招募公告列明了该职位的职责，包括对所有投稿作出最终决定。
• The journal communicates through social media channels that include a widely followed account and podcast and video content期刊通过社交媒体渠道传播，包括关注度较高的账号以及播客与视频内容。
• Manuscripts are peer reviewed, and the journal is indexed in MEDLINE, Scopus and the Science Citation Index Expanded稿件经同行评审，期刊被（MEDLINE）、（Scopus）与（Science Citation Index Expanded）收录。